Did a Romanian physician discover the secret to slowing down the aging process?
In short: Ana Aslan was a pioneering gerontologist who challenged medical norms to investigate the biology of aging. By repurposing procaine, she developed Gerovital H3, a treatment that drew global attention from celebrities and politicians alike. Her work sparked intense debate over whether science could truly offer a fountain of youth.
Born in 1897, Ana Aslan defied the social constraints of her era to pursue medicine, famously staging a hunger strike to secure her mother's approval for her studies. After earning her medical degree in 1924, she dedicated her career to cardiovascular physiology and the mechanisms of aging. Her breakthrough occurred while studying the effects of procaine on arthritis, where she observed unexpected systemic benefits that led to the creation of Gerovital H3.
Aslan faced significant skepticism from the scientific community regarding her claims. To validate her findings, she launched a rigorous two-year study involving 15,000 participants. The results suggested a marked difference in health outcomes: while placebo recipients suffered a 13% mortality rate during a flu epidemic, those treated with her drug saw that figure drop to 2.7%. Additionally, 40% of the treated group reported fewer days lost to illness. These findings helped cement her reputation, leading to her leadership of the National Institute of Geriatrics and Gerontology in Bucharest from 1958 until her death in 1988.
Beyond her clinical research, Aslan was a visionary in social medicine. In 1959, she established the Romanian Society of Gerontology and Geriatrics, the first organization globally to integrate clinical, experimental, and social research into a unified strategy for preventing aging. Her influence extended to the commercial sector, where she patented cosmetic applications of her formulas. While modern versions of these products have since removed the original procaine hydrochloride, Aslan’s legacy remains tied to her early, ambitious attempts to medically intervene in the natural progression of human senescence.
Throughout her life, Aslan received numerous international honors, including the Leon Bernard Prize from the World Health Organization in 1982. Her clinics attracted high-profile figures, including John F. Kennedy, who sought her treatments. Despite the controversy surrounding her work, her institutional contributions to geriatrics established a framework for national health networks focused on aging that persists today.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Ana Aslan
To cite this card, link to https://intellectplus.co.uk/app/technology-ana-aslan.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Medicine · More in Health · Latest · A–Z · All topics